Compare $ONCO vs $REVB | Chartloom

Compare

$ONCO vs $REVB

Onconetix Inc · Revelation Biosciences Inc

ONCO

Onconetix Inc

REVB

Revelation Biosciences Inc

Compare $ONCO vs $REVB

Comparing Onconetix Inc and Revelation Biosciences Inc

ONCOOnconetix Inc

REVBRevelation Biosciences Inc

ONCOOnconetix Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.3%

YTD performance

-99.2%

52W performance

-99.7%

FCF yield

-420.9%

REVBRevelation Biosciences Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-76.6%

52W performance

-87.1%

FCF yield

-317.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ONCO

REVB

Detailed metrics comparison

ONCO

Onconetix Inc

REVB

Revelation Biosciences Inc

Market Cap

ONCO$2M

REVB$3M

Enterprise Value

ONCO$-3M

REVB$-9M

Price

ONCO$0.62

REVB$0.76

P/E Ratio

ONCON/A

REVBN/A

P/S Ratio

ONCO3.79x

REVB0.00x

EV/Sales

ONCO-5.18x

REVB0.00x

EV/EBITDA

ONCO0.00x

REVB0.00x

P/B Ratio

ONCO0.24x

REVB0.30x

P/FCF Ratio

ONCON/A

REVBN/A

EV/FCF

ONCO0.32x

REVB0.90x

PEG Ratio

ONCON/A

REVBN/A

Forward P/E (NTM)

ONCON/A

REVBN/A

Forward P/S (NTM)

ONCON/A

REVBN/A

Revenue (TTM)

ONCO$646K

REVB$0

Revenue Growth (YoY)

ONCO-51.3%

REVBN/A

Forward Rev Growth

ONCO0.0%

REVB115.3%

Gross Margin (TTM)

ONCO80.4%

REVB0.0%

Operating Margin (TTM)

ONCO0.0%

REVB0.0%

EBITDA Margin (TTM)

ONCO-1188.1%

REVB0.0%

Net Margin (TTM)

ONCO-1578.8%

REVB0.0%

FCF Margin (TTM)

ONCO-1596.2%

REVBN/A

Net Income (TTM)

ONCO$-10M

REVB$-19M

FCF (TTM)

ONCO$-10M

REVB$-9M

EPS (TTM)

ONCO-$4.55

REVB-$5.01

ROE (TTM)

ONCO-9194.0%

REVB-10020.0%

ROA (TTM)

ONCO-5376.0%

REVB-8273.0%

ROIC (TTM)

ONCO-9080.0%

REVB-10020.0%

Cash

ONCO$6M

REVB$11M

Debt

ONCO$150K

REVB$0

Net Cash/Debt

ONCO$6M

REVB$11M

Current Ratio (TTM)

ONCO2.21x

REVB6.21x

Quick Ratio (TTM)

ONCO2.04x

REVB6.11x

Debt/Equity (TTM)

ONCO0.01x

REVB0.00x

Debt/Assets (TTM)

ONCO0.0%

REVB0.0%

Interest Coverage (TTM)

ONCON/A

REVBN/A

Net Debt/EBITDA (TTM)

ONCO0.00x

REVB0.00x

Beta

ONCO2.60

REVB-0.14

52W Performance

ONCO-99.7%

REVB-87.1%

YTD Performance

ONCO-99.2%

REVB-76.6%

% from 52W High

ONCO-99.7%

REVB-87.8%

% from 52W Low

ONCO6.9%

REVB1.3%

Asset Turnover (TTM)

ONCO0.03x

REVB0.00x

FCF Yield (TTM)

ONCO-420.9%

REVB-317.7%

Earnings Yield (TTM)

ONCO-416.3%

REVB-646.3%

Dividend Yield (TTM)

ONCON/A

REVBN/A

Rule of 40

ONCO-1,647.5

REVB0.0

EV/GP/RG

ONCON/A

REVBN/A

Ticker research

View ONCO research View REVB research

Metric	ONCO Onconetix Inc	REVB Revelation Biosciences Inc
Market & Valuation
Market Cap	$2M	$3M
Enterprise Value	$-3M	$-9M
Price	$0.62	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	3.79x	0.00x
EV/Sales	-5.18x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.24x	0.30x
P/FCF Ratio	N/A	N/A
EV/FCF	0.32x	0.90x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$646K	$0
Revenue Growth (YoY)	-51.3%	N/A
Forward Rev Growth	0.0%	115.3%
Profitability
Gross Margin (TTM)	80.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1188.1%	0.0%
Net Margin (TTM)	-1578.8%	0.0%
FCF Margin (TTM)	-1596.2%	N/A
Net Income (TTM)	$-10M	$-19M
FCF (TTM)	$-10M	$-9M
EPS (TTM)	-$4.55	-$5.01
ROE (TTM)	-9194.0%	-10020.0%
ROA (TTM)	-5376.0%	-8273.0%
ROIC (TTM)	-9080.0%	-10020.0%
Financial Health
Cash	$6M	$11M
Debt	$150K	$0
Net Cash/Debt	$6M	$11M
Current Ratio (TTM)	2.21x	6.21x
Quick Ratio (TTM)	2.04x	6.11x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	-0.14
52W Performance	-99.7%	-87.1%
YTD Performance	-99.2%	-76.6%
% from 52W High	-99.7%	-87.8%
% from 52W Low	6.9%	1.3%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.00x
FCF Yield (TTM)	-420.9%	-317.7%
Earnings Yield (TTM)	-416.3%	-646.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,647.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ONCO research	View REVB research

Valuation

P/S Ratio

REVB

0.00x

ONCO

3.79x

EV/FCF

ONCO

0.32x

REVB

0.90x

Growth & revenue

Revenue Growth TTM

ONCO

-51.3%

Forward Revenue Growth

REVB

115.3%

ONCO

0.0%

Profitability & performance

Gross Margin

ONCO

80.4%

REVB

0.0%

ROE

ONCO

-9194.0%

REVB

-10020.0%

FCF Yield %

REVB

-317.7%

ONCO

-420.9%

52-Week Performance

REVB

-87.1%

ONCO

-99.7%

Detailed metrics comparison

ONCO

Onconetix Inc

REVB

Revelation Biosciences Inc

Market Cap

ONCO$2M

REVB$3M

Enterprise Value

ONCO$-3M

REVB$-9M

Price

ONCO$0.62

REVB$0.76

P/E Ratio

ONCON/A

REVBN/A

P/S Ratio

ONCO3.79x

REVB0.00x

EV/Sales

ONCO-5.18x

REVB0.00x

EV/EBITDA

ONCO0.00x

REVB0.00x

P/B Ratio

ONCO0.24x

REVB0.30x

P/FCF Ratio

ONCON/A

REVBN/A

EV/FCF

ONCO0.32x

REVB0.90x

PEG Ratio

ONCON/A

REVBN/A

Forward P/E (NTM)

ONCON/A

REVBN/A

Forward P/S (NTM)

ONCON/A

REVBN/A

Revenue (TTM)

ONCO$646K

REVB$0

Revenue Growth (YoY)

ONCO-51.3%

REVBN/A

Forward Rev Growth

ONCO0.0%

REVB115.3%

Gross Margin (TTM)

ONCO80.4%

REVB0.0%

Operating Margin (TTM)

ONCO0.0%

REVB0.0%

EBITDA Margin (TTM)

ONCO-1188.1%

REVB0.0%

Net Margin (TTM)

ONCO-1578.8%

REVB0.0%

FCF Margin (TTM)

ONCO-1596.2%

REVBN/A

Net Income (TTM)

ONCO$-10M

REVB$-19M

FCF (TTM)

ONCO$-10M

REVB$-9M

EPS (TTM)

ONCO-$4.55

REVB-$5.01

ROE (TTM)

ONCO-9194.0%

REVB-10020.0%

ROA (TTM)

ONCO-5376.0%

REVB-8273.0%

ROIC (TTM)

ONCO-9080.0%

REVB-10020.0%

Cash

ONCO$6M

REVB$11M

Debt

ONCO$150K

REVB$0

Net Cash/Debt

ONCO$6M

REVB$11M

Current Ratio (TTM)

ONCO2.21x

REVB6.21x

Quick Ratio (TTM)

ONCO2.04x

REVB6.11x

Debt/Equity (TTM)

ONCO0.01x

REVB0.00x

Debt/Assets (TTM)

ONCO0.0%

REVB0.0%

Interest Coverage (TTM)

ONCON/A

REVBN/A

Net Debt/EBITDA (TTM)

ONCO0.00x

REVB0.00x

Beta

ONCO2.60

REVB-0.14

52W Performance

ONCO-99.7%

REVB-87.1%

YTD Performance

ONCO-99.2%

REVB-76.6%

% from 52W High

ONCO-99.7%

REVB-87.8%

% from 52W Low

ONCO6.9%

REVB1.3%

Asset Turnover (TTM)

ONCO0.03x

REVB0.00x

FCF Yield (TTM)

ONCO-420.9%

REVB-317.7%

Earnings Yield (TTM)

ONCO-416.3%

REVB-646.3%

Dividend Yield (TTM)

ONCON/A

REVBN/A

Rule of 40

ONCO-1,647.5

REVB0.0

EV/GP/RG

ONCON/A

REVBN/A

Ticker research

View ONCO research View REVB research

Metric	ONCO Onconetix Inc	REVB Revelation Biosciences Inc
Market & Valuation
Market Cap	$2M	$3M
Enterprise Value	$-3M	$-9M
Price	$0.62	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	3.79x	0.00x
EV/Sales	-5.18x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.24x	0.30x
P/FCF Ratio	N/A	N/A
EV/FCF	0.32x	0.90x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$646K	$0
Revenue Growth (YoY)	-51.3%	N/A
Forward Rev Growth	0.0%	115.3%
Profitability
Gross Margin (TTM)	80.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1188.1%	0.0%
Net Margin (TTM)	-1578.8%	0.0%
FCF Margin (TTM)	-1596.2%	N/A
Net Income (TTM)	$-10M	$-19M
FCF (TTM)	$-10M	$-9M
EPS (TTM)	-$4.55	-$5.01
ROE (TTM)	-9194.0%	-10020.0%
ROA (TTM)	-5376.0%	-8273.0%
ROIC (TTM)	-9080.0%	-10020.0%
Financial Health
Cash	$6M	$11M
Debt	$150K	$0
Net Cash/Debt	$6M	$11M
Current Ratio (TTM)	2.21x	6.21x
Quick Ratio (TTM)	2.04x	6.11x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	-0.14
52W Performance	-99.7%	-87.1%
YTD Performance	-99.2%	-76.6%
% from 52W High	-99.7%	-87.8%
% from 52W Low	6.9%	1.3%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.00x
FCF Yield (TTM)	-420.9%	-317.7%
Earnings Yield (TTM)	-416.3%	-646.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,647.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ONCO research	View REVB research